Last reviewed · How we verify
NCT03482934
Predictors of Left Ventricular Hypertrophy in Hypertensive Patients in Assiut Governorate
trial testing sphygmomanometer in HTN in 300 participants. Completed in 30 September 2020.
30 September 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 October 2019 |
| Primary completion | 30 September 2020 |
| Estimated completion | 30 September 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- sphygmomanometer
- mobilogragh
- ECG
- Echocardiography
Conditions studied
- HTN — all drugs for HTN →
- Hypertrophy, Left Ventricular — all drugs for Hypertrophy, Left Ventricular →
Sponsor
Assiut University
Who can join
18 and older, any sex, with HTN or Hypertrophy, Left Ventricular. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To recognize predictors of left ventricular hypertrophy in hypertensive patients in Assiut government \& to recognize the prognostic effect of central blood pressure measurement versus office brachial blood pressure measurement.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03482934
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of sphygmomanometer
Trials testing the same drug.
- NCT06513975 — Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor · NA · recruiting
- NCT05909605 — Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor · completed
Other recruiting trials for HTN
Currently open trials in the same condition.
- NCT05850416 — mGlide-Care: A Partnership With Caregivers · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03482934 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 29 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03482934.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing